White Paper

Navigating Key Complexities in the Development of Cell and Gene Therapies 

Cell and gene therapies are unique and relatively untested drugs. Typically, the public may not reap the therapy’s benefits for years since each therapy is tailored to an individual’s genome. Paired with market volatility and operational challenges, biotech organizations are always facing navigational challenges as they bring these therapies to market.

There are many evolving regulatory guidelines, recruitment challenges, and economic uncertainty pertaining to cell and gene therapy – how do organizations navigate it all?

Download our white paper exploring the uniquely complex situations cell and gene therapy presents in research.

Who Should Watch?

CEU Credits

Certificate of Attendance

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Download Now